Emicizumab-kxwh Subcutaneous and Tavist Allergy
Determining the interaction of Emicizumab-kxwh Subcutaneous and Tavist Allergy and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: clemastine
Brand name: Tavist Allergy, Tavist, Tavist-1, Allerhist-1, Dailyhist-1, Contac 12 Hour Allergy, Dayhist Allergy
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Tavist ND
- Emicizumab-kxwh Subcutaneous-Tavist Sinus
- Emicizumab-kxwh Subcutaneous-Taxol
- Emicizumab-kxwh Subcutaneous-Taxotere
- Emicizumab-kxwh Subcutaneous-Taytulla
- Emicizumab-kxwh Subcutaneous-Taytulla birth control
- Tavist Allergy-Emla
- Tavist Allergy-Emla Topical
- Tavist Allergy-Emo-Cort Scalp Solution Topical application
- Tavist Allergy-Emo-Cort Topical application
- Tavist Allergy-Emoquette
- Tavist Allergy-Empagliflozin